These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2459312

  • 1. Characterization of dopamine and beta-adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma.
    Balmforth AJ, Yasunari K, Vaughan PF, Ball SG.
    J Neurochem; 1988 Nov; 51(5):1510-5. PubMed ID: 2459312
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
    Andringa G, Drukarch B, Leysen JE, Cools AR, Stoof JC.
    Eur J Pharmacol; 1999 Jan 01; 364(1):33-41. PubMed ID: 9920182
    [Abstract] [Full Text] [Related]

  • 6. Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices.
    Kelly E, Nahorski SR.
    J Neurochem; 1986 Nov 01; 47(5):1512-6. PubMed ID: 2428936
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M.
    J Neurochem; 1987 Oct 01; 49(4):1042-9. PubMed ID: 2957468
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF.
    Am J Physiol; 1998 Oct 01; 275(4):E687-93. PubMed ID: 9755089
    [Abstract] [Full Text] [Related]

  • 17. Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells.
    Sidhu A, Olde B, Humblot N, Kimura K, Gardner N.
    Neuroscience; 1999 Oct 01; 91(2):537-47. PubMed ID: 10366011
    [Abstract] [Full Text] [Related]

  • 18. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
    Weiss S, Sebben M, Garcia-Sainz JA, Bockaert J.
    Mol Pharmacol; 1985 Jun 01; 27(6):595-9. PubMed ID: 2987658
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA, Pollock NJ, Frail DE, Paxson CL, Rakowski RF, Kang CH, Kebabian JW.
    Br J Pharmacol; 1991 Dec 01; 104(4):1038-44. PubMed ID: 1687364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.